Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunothrombosis: A key mechanism in the COVID-19 pandemic.
Páramo JA, Marcos-Jubilar M. Páramo JA, et al. Among authors: marcos jubilar m. Med Clin (Barc). 2024 Nov 29;163(10):517-521. doi: 10.1016/j.medcli.2024.05.027. Epub 2024 Jul 30. Med Clin (Barc). 2024. PMID: 39085002 English, Spanish. No abstract available.
Factor XI inhibitors: A new era in antithrombotic therapy.
Páramo JA, Marcos-Jubilar M. Páramo JA, et al. Among authors: marcos jubilar m. Med Clin (Barc). 2024 Jan 26;162(2):73-76. doi: 10.1016/j.medcli.2023.09.003. Epub 2023 Oct 18. Med Clin (Barc). 2024. PMID: 37863734 English, Spanish. No abstract available.
Analysis of common biomarkers in capillary blood in routine clinical laboratory. Preanalytical and analytical comparison with venous blood.
Maroto-García J, Deza S, Fuentes-Bullejos P, Fernández-Tomás P, Martínez-Espartosa D, Marcos-Jubilar M, Varo N, González Á. Maroto-García J, et al. Among authors: marcos jubilar m. Diagnosis (Berl). 2023 Mar 7;10(3):281-297. doi: 10.1515/dx-2022-0126. eCollection 2023 Aug 1. Diagnosis (Berl). 2023. PMID: 36877154
Thromboprophylaxis in Patients With Cancer and COVID-19.
Lecumberri R, Marcos-Jubilar M, Guillén C. Lecumberri R, et al. Among authors: marcos jubilar m. Arch Bronconeumol. 2022 Nov;58(11):744-745. doi: 10.1016/j.arbres.2022.08.006. Epub 2022 Sep 8. Arch Bronconeumol. 2022. PMID: 36153216 Free PMC article. No abstract available.
11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value.
Morales-Lozano MI, Rodriguez-Otero P, Sancho L, Nuñez-Cordoba JM, Prieto E, Marcos-Jubilar M, Rosales JJ, Alfonso A, Guillen EF, San-Miguel J, Garcia-Velloso MJ. Morales-Lozano MI, et al. Among authors: marcos jubilar m. Int J Mol Sci. 2022 Aug 31;23(17):9895. doi: 10.3390/ijms23179895. Int J Mol Sci. 2022. PMID: 36077292 Free PMC article.
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Bailén R, Pascual-Cascón MJ, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, López-Godino O, Martín-Calvo C, Fernández-Caldas P, Marcos-Jubilar M, Sánchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Díez-Martín JL, Kwon M; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Bailén R, et al. Among authors: marcos jubilar m. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. Transplant Cell Ther. 2022. PMID: 35108627 Free article.
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial.
Marcos-Jubilar M, Carmona-Torre F, Vidal R, Ruiz-Artacho P, Filella D, Carbonell C, Jiménez-Yuste V, Schwartz J, Llamas P, Alegre F, Sádaba B, Núñez-Córdoba J, Yuste JR, Fernández-García J, Lecumberri R; BEMICOP Investigators. Marcos-Jubilar M, et al. Thromb Haemost. 2022 Feb;122(2):295-299. doi: 10.1055/a-1667-7534. Epub 2021 Dec 29. Thromb Haemost. 2022. PMID: 34638151 Free article. Clinical Trial.
Impact of the mutation profile on thrombotic risk in cancer patients.
Páramo JA, Marcos-Jubilar M, Lecumberri R. Páramo JA, et al. Among authors: marcos jubilar m. Rev Clin Esp (Barc). 2022 Feb;222(2):93-99. doi: 10.1016/j.rceng.2021.04.008. Epub 2021 Sep 20. Rev Clin Esp (Barc). 2022. PMID: 34548256 Review.
16 results